ConductScience.org, home

Paper39210306

Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior.

Gu X and 3 others. BMC Cancer, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior. Papers, record 39210306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39210306

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior.
PubMed
Journal
BMC Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.63, provisional
iCite
Revised in PubMed
2024-09-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gu XXuefeng
2Wei YYanyan
3Shen DDuo
4Mao YYuan

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
RNA, Long NoncodingMajor topic
Humans
Prognosis
Male
Biomarkers, Tumor
Female
Gene Expression Regulation, Neoplastic
Middle Aged
Cell Proliferation
Cell Line, Tumor
Computational Biology

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127102039Cystinosis: a review.Orphanet J Rare Dis2016https://conductscience.org/library/papers/27102039PubMed
212189052Biological regulation through protein disulfide bond cleavage.Redox Rep2002https://conductscience.org/library/papers/12189052PubMed
337152941Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37152941PubMed
432481346Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma.Medicine (Baltimore)2020https://conductscience.org/library/papers/32481346PubMed
535624210Epigenetic regulation of T cell exhaustion.Nat Immunol2022https://conductscience.org/library/papers/35624210PubMed
636965032Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacity.Mol Oncol2023https://conductscience.org/library/papers/36965032PubMed
736747082Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.Nat Cell Biol2023https://conductscience.org/library/papers/36747082PubMed
829075797[Early stage liver cancer : Hepatocellular carcinoma].Chirurg2018https://conductscience.org/library/papers/29075797PubMed
935068855Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma.World J Gastroenterol2021https://conductscience.org/library/papers/35068855PubMed
1032285278Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.Ann Surg Oncol2020https://conductscience.org/library/papers/32285278PubMed
1133391418LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma.J Cancer2021https://conductscience.org/library/papers/33391418PubMed
1237101248Disulfidptosis: a new target for metabolic cancer therapy.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37101248PubMed
1335138470SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition.Biochem Genet2022https://conductscience.org/library/papers/35138470PubMed
1436695827Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.Cancer Immunol Immunother2023https://conductscience.org/library/papers/36695827PubMed
1534903711HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.Cell Death Dis2021https://conductscience.org/library/papers/34903711PubMed
1636973424E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.Cancer Gene Ther2023https://conductscience.org/library/papers/36973424PubMed
1735634426Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study.Liver Cancer2022https://conductscience.org/library/papers/35634426PubMed
1825685869Cystinuria: current concepts and future directions.Clin Nephrol2015https://conductscience.org/library/papers/25685869PubMed
1933000222Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.Int J Mol Med2020https://conductscience.org/library/papers/33000222PubMed
2037575978Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature.Genet Res (Camb)2023https://conductscience.org/library/papers/37575978PubMed

See all 45 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40892177Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma.Discov Oncol2025https://conductscience.org/library/papers/40892177PubMed
40790550Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective.BMC Gastroenterol2025https://conductscience.org/library/papers/40790550PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
KDM4A9682PubTator's text mininghttps://conductscience.org/library/genes/9682NCBI Gene
MKLN14289PubTator's text mininghttps://conductscience.org/library/genes/4289NCBI Gene
TMCC123023PubTator's text mininghttps://conductscience.org/library/genes/23023NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39210306

GET https://conductscience.org/api/papers/v1/39210306/references?page=2